By Professor Glenda Halliday

Journal articles

Tan RH; Ke YD; Ittner LM; Halliday GM, 2017, 'ALS/FTLD: experimental models and reality', Acta Neuropathologica, 133, pp. 177 - 196, http://dx.doi.org/10.1007/s00401-016-1666-6

Damian DL; Martin AJ; Scolyer RA; Chen AC; Halliday GM, 2017, 'Authors' response to a reply to ‘A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients’', British Journal of Dermatology, 176, pp. 552 - 553, http://dx.doi.org/10.1111/bjd.15204

Ferrari R; Wang Y; Vandrovcova J; Guelfi S; Witeolar A; Karch CM; Schork AJ; Fan CC; Brewer JB; Momeni P; Schellenberg GD; Dillon WP; Sugrue LP; Hess CP; Yokoyama JS; Bonham LW; Rabinovici GD; Miller BL; Andreassen OA; Dale AM; Hardy J; Desikan RS; Ferrari R; Hernandez DG; Nalls MA; Rohrer JD; Ramasamy A; Kwok JBJ; Dobson-Stone C; Schofield PR; Halliday GM; Hodges JR; Piguet O; Bartley L; Thompson E; Haan E; Hernández I; Ruiz A; Boada M; Borroni B; Padovani A; Cruchaga C; Cairns NJ; Benussi L; Binetti G; Ghidoni R; Forloni G; Albani D; Galimberti D; Fenoglio C; Serpente M; Scarpini E; Clarimón J; Lleó A; Blesa R; Landqvist Waldö M; Nilsson K; Nilsson C; Mackenzie IRA; Hsiung GYR; Mann DMA; Grafman J; Morris CM; Attems J; Griffiths TD; McKeith IG; Thomas AJ; Pietrini P; Huey ED; Wassermann EM; Baborie A; Jaros E; Tierney MC; Pastor P; Razquin C; Ortega-Cubero S; Alonso E; Perneczky R; Diehl-Schmid J; Alexopoulos P; Kurz A; Rainero I; Rubino E; Pinessi L; Rogaeva E; St George-Hyslop P; Rossi G; Tagliavini F; Giaccone G; Rowe JB; Schlachetzki JCM; Uphill J; Collinge J; Mead S; Danek A; Van Deerlin VM; Grossman M; Trojanowski JQ; van der Zee J; Cruts M, 2017, 'Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimer's and Parkinson's diseases', Journal of Neurology Neurosurgery and Psychiatry, 88, pp. 152 - 164, http://dx.doi.org/10.1136/jnnp-2016-314411

Surmeier DJ; Obeso JA; Halliday GM, 2017, 'Selective neuronal vulnerability in Parkinson disease', Nature Reviews Neuroscience, 18, pp. 101 - 113, http://dx.doi.org/10.1038/nrn.2016.178

Dzamko N; Gysbers A; Perera G; Bahar A; Shankar A; Gao J; Fu YH; Halliday GM, 2017, 'Toll-like receptor 2 is increased in neurons in Parkinson’s disease brain and may contribute to alpha-synuclein pathology', Acta Neuropathologica, 133, pp. 303 - 319, http://dx.doi.org/10.1007/s00401-016-1648-8

Kun-Rodrigues C; Ross OA; Orme T; Shepherd C; Parkkinen L; Darwent L; Hernandez D; Ansorge O; Clark LN; Honig LS; Marder K; Lemstra A; Scheltens P; van der Flier W; Louwersheimer E; Holstege H; Rogaeva E; St. George-Hyslop P; Londos E; Zetterberg H; Barber I; Braae A; Brown K; Morgan K; Maetzler W; Berg D; Troakes C; Al-Sarraj S; Lashley T; Holton J; Compta Y; Van Deerlin V; Trojanowski JQ; Serrano GE; Beach TG; Clarimon J; Lleó A; Morenas-Rodríguez E; Lesage S; Galasko D; Masliah E; Santana I; Diez M; Pastor P; Tienari PJ; Myllykangas L; Oinas M; Revesz T; Lees A; Boeve BF; Petersen RC; Ferman TJ; Escott-Price V; Graff-Radford N; Cairns NJ; Morris JC; Stone DJ; Pickering-Brown S; Mann D; Dickson DW; Halliday GM; Singleton A; Guerreiro R; Bras J, 2017, 'Analysis of C9orf72 repeat expansions in a large international cohort of dementia with Lewy bodies', Neurobiology of Aging, 49, pp. 214 - 214.e15, http://dx.doi.org/10.1016/j.neurobiolaging.2016.08.023

Burrell JR; Ballard KJ; Halliday GM; Hodges JR, 2017, 'Aphasia in Progressive Supranuclear Palsy: As Severe as Progressive Non-Fluent Aphasia', Journal of Alzheimer S Disease, 61, pp. 705 - 715, http://dx.doi.org/10.3233/JAD-170743

Tan RH; Kril JJ; Yang Y; Tom N; Hodges JR; Villemagne VL; Rowe CC; Leyton CE; Kwok JBJ; Ittner LM; Halliday GM, 2017, 'Assessment of amyloid β in pathologically confirmed frontotemporal dementia syndromes', Alzheimer S and Dementia Diagnosis Assessment and Disease Monitoring, 9, pp. 10 - 20, http://dx.doi.org/10.1016/j.dadm.2017.05.005

Bhatia S; Fu YH; Hsiao JHT; Halliday GM; Kim WS, 2017, 'Deletion of Alzheimer's Disease Risk Gene ABCA7 Alters White Adipose Tissue Development and Leptin Levels', Journal of Alzheimer S Disease Reports, 1, pp. 237 - 247, http://dx.doi.org/10.3233/ADR-170029

Kirik D; Cederfjäll E; Halliday G; Petersén , 2017, 'Gene therapy for Parkinson's disease: Disease modification by GDNF family of ligands', Neurobiology of Disease, 97, pp. 179 - 188, http://dx.doi.org/10.1016/j.nbd.2016.09.008

Ahmed RM; Highton-Williamson E; Caga J; Thornton N; Ramsey E; Zoing M; Kim WS; Halliday GM; Piguet O; Hodges JR; Farooqi IS; Kiernan MC, 2017, 'Lipid Metabolism and Survival Across the Frontotemporal Dementia-Amyotrophic Lateral Sclerosis Spectrum: Relationships to Eating Behavior and Cognition', Journal of Alzheimer S Disease, 61, pp. 773 - 783, http://dx.doi.org/10.3233/JAD-170660

Van Langenhove T; Piguet O; Burrell JR; Leyton C; Foxe D; Abela M; Bartley L; Kim WS; Jary E; Huang Y; Dobson-Stone C; Kwok JB; Halliday GM; Hodges JR, 2017, 'Predicting Development of Amyotrophic Lateral Sclerosis in Frontotemporal Dementia', Journal of Alzheimer S Disease, 58, pp. 163 - 170, http://dx.doi.org/10.3233/JAD-161272

Purves-Tyson TD; Owens SJ; Rothmond DA; Halliday GM; Double KL; Stevens J; McCrossin T; Shannon Weickert C, 2017, 'Putative presynaptic dopamine dysregulation in schizophrenia is supported by molecular evidence from post-mortem human midbrain', Translational Psychiatry, 7, pp. e1003 - e1003, http://dx.doi.org/10.1038/tp.2016.257

Kordower JH; Goetz CG; Chu Y; Halliday GM; Nicholson DA; Musial TF; Marmion DJ; Stoessl AJ; Sossi V; Freeman TB; Olanow CW, 2017, 'Robust graft survival and normalized dopaminergic innervation do not obligate recovery in a Parkinson disease patient', Annals of Neurology, 81, pp. 46 - 57, http://dx.doi.org/10.1002/ana.24820

Devenney EM; Landin-Romero R; Irish M; Hornberger M; Mioshi E; Halliday GM; Kiernan MC; Hodges JR, 2017, 'The neural correlates and clinical characteristics of psychosis in the frontotemporal dementia continuum and the C9orf72 expansion', Neuroimage Clinical, 13, pp. 439 - 445, http://dx.doi.org/10.1016/j.nicl.2016.11.028

Yang Y; Halliday GM; Hodges JR; Tan RH, 2017, 'Von Economo Neuron Density and Thalamus Volumes in Behavioral Deficits in Frontotemporal Dementia Cases with and without a C9ORF72 Repeat Expansion', Journal of Alzheimer S Disease, 58, pp. 701 - 709, http://dx.doi.org/10.3233/JAD-170002

Halliday GM, 2017, '[S3–01–01]: MIXED PATHOLOGY IN ALZHEIMER's DISEASE', Alzheimer's & Dementia, 13, http://dx.doi.org/10.1016/j.jalz.2017.07.254

Chen AC; Martin AJ; Dalziell RA; Halliday GM; Damian DL, 2016, 'Oral nicotinamide reduces transepidermal water loss: a randomized controlled trial', British Journal of Dermatology, 175, pp. 1363 - 1365, http://dx.doi.org/10.1111/bjd.14648

Weissleder C; Fung SJ; Wong MW; Barry G; Double KL; Halliday GM; Webster MJ; Weickert CS, 2016, 'Decline in proliferation and immature neuron markers in the human subependymal zone during aging: Relationship to EGF- and FGF-related transcripts', Frontiers in Aging Neuroscience, 8, pp. 274, http://dx.doi.org/10.3389/fnagi.2016.00274

Hu YB; Zou Y; Huang Y; Zhang YF; Lourenco GF; Chen SD; Halliday GM; Wang G; Ren RJ, 2016, 'ROCK1 is associated with Alzheimer’s disease-specific plaques, as well as enhances autophagosome formation but not autophagic Aβ clearance', Frontiers in Cellular Neuroscience, 10, http://dx.doi.org/10.3389/fncel.2016.00253

Postuma RB; Berg D; Stern M; Poewe W; Olanow CW; Oertel W; Marek K; Litvan I; Lang AE; Halliday G; Goetz CG; Gasser T; Dubois B; Chan P; Bloem BR; Adler CH; Deuschl G, 2016, 'Abolishing the 1-year rule: How much evidence will be enough?', Movement Disorders, 31, pp. 1623 - 1627, http://dx.doi.org/10.1002/mds.26796

Chen BJ; Mills JD; Takenaka K; Bliim N; Halliday GM; Janitz M, 2016, 'Characterization of circular RNAs landscape in multiple system atrophy brain', Journal of Neurochemistry, 139, pp. 485 - 496, http://dx.doi.org/10.1111/jnc.13752

Ahmed RM; Devenney EM; Irish M; Ittner A; Naismith S; Ittner LM; Rohrer JD; Halliday GM; Eisen A; Hodges JR; Kiernan MC, 2016, 'Neuronal network disintegration: Common pathways linking neurodegenerative diseases', Journal of Neurology Neurosurgery and Psychiatry, 87, pp. 1234 - 1241, http://dx.doi.org/10.1136/jnnp-2014-308350

Guerreiro R; Escott-Price V; Darwent L; Parkkinen L; Ansorge O; Hernandez DG; Nalls MA; Clark L; Honig L; Marder K; van der Flier W; Holstege H; Louwersheimer E; Lemstra A; Scheltens P; Rogaeva E; St George-Hyslop P; Londos E; Zetterberg H; Ortega-Cubero S; Pastor P; Ferman TJ; Graff-Radford NR; Ross OA; Barber I; Braae A; Brown K; Morgan K; Maetzler W; Berg D; Troakes C; Al-Sarraj S; Lashley T; Compta Y; Revesz T; Lees A; Cairns NJ; Halliday GM; Mann D; Pickering-Brown S; Powell J; Lunnon K; Lupton MK; Dickson D; Hardy J; Singleton A; Bras J, 2016, 'Genome-wide analysis of genetic correlation in dementia with Lewy bodies, Parkinson's and Alzheimer's diseases', Neurobiology of Aging, 38, pp. 214.e7 - 214.e10, http://dx.doi.org/10.1016/j.neurobiolaging.2015.10.028

Fu YH; Paxinos G; Watson C; Halliday GM, 2016, 'The substantia nigra and ventral tegmental dopaminergic neurons from development to degeneration', Journal of Chemical Neuroanatomy, 76, pp. 98 - 107, http://dx.doi.org/10.1016/j.jchemneu.2016.02.001

Perera G; Ranola M; Rowe DB; Halliday GM; Dzamko N, 2016, 'Inhibitor treatment of peripheral mononuclear cells from Parkinson's disease patients further validates LRRK2 dephosphorylation as a pharmacodynamic biomarker', Scientific Reports, 6, http://dx.doi.org/10.1038/srep31391

Fu Y; Hsiao JHT; Paxinos G; Halliday GM; Kim WS, 2016, 'ABCA7 Mediates Phagocytic Clearance of Amyloid-β in the Brain', Journal of Alzheimer S Disease, 54, pp. 569 - 584, http://dx.doi.org/10.3233/JAD-160456

Burrell JR; Halliday GM; Kril JJ; Ittner LM; Götz J; Kiernan MC; Hodges JR, 2016, 'The frontotemporal dementia-motor neuron disease continuum', Lancet, 388, pp. 919 - 931, http://dx.doi.org/10.1016/S0140-6736(16)00737-6

Landeck N; Hall H; Ardah MT; Majbour NK; El-Agnaf OMA; Halliday G; Kirik D, 2016, 'A novel multiplex assay for simultaneous quantification of total and S129 phosphorylated human alpha-synuclein', Molecular Neurodegeneration, 11, http://dx.doi.org/10.1186/s13024-016-0125-0

Shibuya K; Park SB; Geevasinga N; Menon P; Howells J; Simon NG; Huynh W; Noto YI; Götz J; Kril JJ; Ittner LM; Hodges J; Halliday G; Vucic S; Kiernan MC, 2016, 'Motor cortical function determines prognosis in sporadic ALS', Neurology, 87, pp. 513 - 520, http://dx.doi.org/10.1212/WNL.0000000000002912

Ahmed RM; Caga J; Devenney E; Hsieh S; Bartley L; Highton-Williamson E; Ramsey E; Zoing M; Halliday GM; Piguet O; Hodges JR; Kiernan MC, 2016, 'Cognition and eating behavior in amyotrophic lateral sclerosis: effect on survival', Journal of Neurology, 263, pp. 1593 - 1603, http://dx.doi.org/10.1007/s00415-016-8168-2

Schott JM; Crutch SJ; Carrasquillo MM; Uphill J; Shakespeare TJ; Ryan NS; Yong KX; Lehmann M; Ertekin-Taner N; Graff-Radford NR; Boeve BF; Murray ME; Khan QUA; Petersen RC; Dickson DW; Knopman DS; Rabinovici GD; Miller BL; González AS; Gil-Néciga E; Snowden JS; Harris J; Pickering-Brown SM; Louwersheimer E; van der Flier WM; Scheltens P; Pijnenburg YA; Galasko D; Sarazin M; Dubois B; Magnin E; Galimberti D; Scarpini E; Cappa SF; Hodges JR; Halliday GM; Bartley L; Carrillo MC; Bras JT; Hardy J; Rossor MN; Collinge J; Fox NC; Mead S, 2016, 'Genetic risk factors for the posterior cortical atrophy variant of Alzheimer's disease', Alzheimer S and Dementia, 12, pp. 862 - 871, http://dx.doi.org/10.1016/j.jalz.2016.01.010

Matrone C; Dzamko N; Madsen P; Nyegaard M; Pohlmann R; Søndergaard RV; Lassen LB; Andresen TL; Halliday GM; Jensen PH; Nielsen MS, 2016, 'Mannose 6-phosphate receptor is reduced in -synuclein overexpressing models of parkinsons disease', Plos One, 11, http://dx.doi.org/10.1371/journal.pone.0160501

Halliday GM; Kiernan MC; Kril JJ; Mito R; Masuda-Suzukake M; Hasegawa M; McCann H; Bartley L; Dobson-Stone C; Kwok JBJ; Hornberger M; Hodges JR; Tan RH, 2016, 'TDP-43 in the hypoglossal nucleus identifies amyotrophic lateral sclerosis in behavioral variant frontotemporal dementia', Journal of the Neurological Sciences, 366, pp. 197 - 201, http://dx.doi.org/10.1016/j.jns.2016.05.005

Dzamko N; Rowe DB; Halliday GM, 2016, 'Increased peripheral inflammation in asymptomatic leucine-rich repeat kinase 2 mutation carriers', Movement Disorders, 31, pp. 889 - 897, http://dx.doi.org/10.1002/mds.26529

Coupland KG; Kim WS; Halliday GM; Hallupp M; Dobson-Stone C; Kwok JBJ, 2016, 'Role of the long non-coding RNA MAPT-AS1 in regulation of microtubule associated protein tau (MAPT) expression in Parkinson's disease', Plos One, 11, pp. e0157924, http://dx.doi.org/10.1371/journal.pone.0157924

Wang G; Huang Y; Wang LL; Zhang YF; Xu J; Zhou Y; Lourenco GF; Zhang B; Wang Y; Ren RJ; Halliday GM; Chen SD, 2016, 'MicroRNA-146a suppresses ROCK1 allowing hyperphosphorylation of tau in Alzheimer's disease', Scientific Reports, 6, http://dx.doi.org/10.1038/srep26697

Mills JD; Ward M; Kim WS; Halliday GM; Janitz M, 2016, 'Strand-specific RNA-sequencing analysis of multiple system atrophy brain transcriptome', Neuroscience, 322, pp. 234 - 250, http://dx.doi.org/10.1016/j.neuroscience.2016.02.042

Postuma RB; Berg D; Adler CH; Bloem BR; Chan P; Deuschl G; Gasser T; Goetz CG; Halliday G; Joseph L; Lang AE; Liepelt-Scarfone I; Litvan I; Marek K; Oertel W; Olanow CW; Poewe W; Stern M, 2016, 'The new definition and diagnostic criteria of Parkinson's disease', Lancet Neurology, 15, pp. 546 - 548, http://dx.doi.org/10.1016/S1474-4422(16)00116-2

Van der Jeugd A; Vermaercke B; Halliday GM; Staufenbiel M; Götz J, 2016, 'Impulsivity, decreased social exploration, and executive dysfunction in a mouse model of frontotemporal dementia', Neurobiology of Learning and Memory, 130, pp. 34 - 43, http://dx.doi.org/10.1016/j.nlm.2016.01.007

O'Callaghan C; Hornberger M; Balsters JH; Halliday GM; Lewis SJG; Shine JM, 2016, 'Cerebellar atrophy in Parkinson's disease and its implication for network connectivity', Brain, 139, pp. 845 - 855, http://dx.doi.org/10.1093/brain/awv399

Wang G; Huang Y; Wei Chen ; Chen S; Wang Y; Xiao Q; Liu J; Fung VSC; Halliday G; Chen S, 2016, 'Variants in the SNCA gene associate with motor progression while variants in the MAPT gene associate with the severity of Parkinson's disease', Parkinsonism and Related Disorders, 24, pp. 89 - 94, http://dx.doi.org/10.1016/j.parkreldis.2015.12.018

Bleasel JM; Halliday GM; Kim WS, 2016, 'Animal modeling an oligodendrogliopathy--multiple system atrophy', Acta Neuropathologica Communications, 4, pp. 12, http://dx.doi.org/10.1186/s40478-016-0279-6

Tan RH; Kril JJ; McGinley C; Hassani M; Masuda-Suzukake M; Hasegawa M; Mito R; Kiernan MC; Halliday GM, 2016, 'Cerebellar neuronal loss in amyotrophic lateral sclerosis cases with ATXN2 intermediate repeat expansions', Annals of Neurology, 79, pp. 295 - 305, http://dx.doi.org/10.1002/ana.24565

McCann H; Cartwright H; Halliday GM, 2016, 'Neuropathology of α-synuclein propagation and braak hypothesis', Movement Disorders, 31, pp. 152 - 160, http://dx.doi.org/10.1002/mds.26421

Chen AC; Martin AJ; Dalziell RA; McKenzie CA; Lowe PM; Eris JM; Scolyer RA; Dhillon HM; Vardy JL; Bielski VA; Halliday GM; Damian DL, 2016, 'A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients', British Journal of Dermatology, 175, pp. 1073 - 1075, http://dx.doi.org/10.1111/bjd.14662

Kovacs GG; Ferrer I; Grinberg LT; Alafuzoff I; Attems J; Budka H; Cairns NJ; Crary JF; Duyckaerts C; Ghetti B; Halliday GM; Ironside JW; Love S; Mackenzie IR; Munoz DG; Murray ME; Nelson PT; Takahashi H; Trojanowski JQ; Ansorge O; Arzberger T; Baborie A; Beach TG; Bieniek KF; Bigio EH; Bodi I; Dugger BN; Feany M; Gelpi E; Gentleman SM; Giaccone G; Hatanpaa KJ; Heale R; Hof PR; Hofer M; Hortobágyi T; Jellinger K; Jicha GA; Ince P; Kofler J; Kövari E; Kril JJ; Mann DM; Matej R; McKee AC; McLean C; Milenkovic I; Montine TJ; Murayama S; Lee EB; Rahimi J; Rodriguez RD; Rozemüller A; Schneider JA; Schultz C; Seeley W; Seilhean D; Smith C; Tagliavini F; Takao M; Thal DR; Toledo JB; Tolnay M; Troncoso JC; Vinters HV; Weis S; Wharton SB; White CL; Wisniewski T; Woulfe JM; Yamada M; Dickson DW, 2016, 'Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy', Acta Neuropathologica, 131, pp. 87 - 102, http://dx.doi.org/10.1007/s00401-015-1509-x

Ahmed RM; Irish M; Piguet O; Halliday GM; Ittner LM; Farooqi S; Hodges JR; Kiernan MC, 2016, 'Amyotrophic lateral sclerosis and frontotemporal dementia: distinct and overlapping changes in eating behaviour and metabolism', Lancet Neurology, 15, pp. 332 - 342, http://dx.doi.org/10.1016/S1474-4422(15)00380-4

Leyton CE; Britton AK; Hodges JR; Halliday GM; Kril JJ, 2016, 'Distinctive pathological mechanisms involved in primary progressive aphasias', Neurobiology of Aging, 38, pp. 82 - 92, http://dx.doi.org/10.1016/j.neurobiolaging.2015.10.017

Burrell JR; Forrest S; Bak TH; Hodges JR; Halliday GM; Kril JJ, 2016, 'Expanding the phenotypic associations of globular glial tau subtypes', Alzheimer S and Dementia Diagnosis Assessment and Disease Monitoring, 4, pp. 6 - 13, http://dx.doi.org/10.1016/j.dadm.2016.03.006

Back to profile page